A systematic study on generating simian immunodeficiency virus (SIV)-based vectors was carried out. The goal was to generate helper-free, replication-defective SIVmac-based vectors at high titers. The general approach was to cotransfect into human 293T cells a plasmid carrying the vector construct along with two helper plasmids that together expressed the SIVmac virion proteins. Initial vectors carried the bacterial ␤-galactosidase gene (␤-gal). These vectors had a technical difficulty: "pseudotransduction" of ␤-gal protein produced during the 293T cell transfections. As a result, infection of cultures with these vector stocks also resulted in passive transfer into, and X-gal staining of, cells that had not actually been infected by the vector. A second generation of vectors expressing the enhanced jellyfish green fluorescence protein (EGFP) was not subject to this artifact. A systematic study of the SIVmac-based EGFP vectors was carried out. Helper-free vector stocks were obtained when helper plasmids lacking the SIVmac packaging signals were used. By employing envelope helper plasmids derived from different SIVmac isolates, it was possible to generate SIVmac-based vectors pseudotyped with envelope proteins of different cell tropism. Optimization of vector and helper plasmid structures, transfection conditions, and infection procedures ultimately yielded vector titers in excess of 10 6 /ml.
INTRODUCTION
Retrovirus-based vectors have been of interest from the point of gene therapy, as well as for studies on retrovirus biology. Initially, vectors based on the simple retroviruses such as murine leukemia virus and spleen necrosis virus received the most attention (Cepko et al., 1984; Hwang and Gilboa, 1984; Rubenstein et al., 1984; Sorge et al., 1984; Stuhlmann et al., 1984; Williams et al., 1984) . More recently, vectors based on HIV have been developed (Buchschacher and Panganiban, 1992; Kalpana, 1999; Shimada et al., 1991; Zufferey et al., 1998) . These latter vectors have the potential advantage of infecting resting cells, due to the fact that accessory and viral structural genes in lentiviruses such as HIV allow infection of resting cells (MA and vpr) (Bukrinsky et al., 1993; Gallay et al., 1995; Heinzinger et al., 1994; Rey et al., 1998; von Schwedler et al., 1994) . On the other hand, generation of lentivirus-based vectors has been challenging because certain viral proteins (e.g., envelope) are toxic to cells, and other proteins (vpr) cause growth arrest (Emerman, 1996; Jowett et al., 1995; Levy et al., 1994; Poon et al., 1998; Rogel et al., 1995) . As a result, it has been difficult to generate efficient packaging cell lines for lentiviral vectors. It has also been difficult to generate high-titer HIV-based vector stocks, unless pseudotypes with the VSV G protein are prepared (Akkina et al., 1996; Chang et al., 1999; Kafri et al., 1999; Li et al., 1998; Mochizuki et al., 1998) .
We have been interested in generating vectors based on simian immunodeficiency virus (SIV) . Such vectors should be analogous to those based on HIV-1; our interest has been driven by a desire to study early events during infection in vivo. In a small animal model, we have been able to observe in vivo infection with helper-free replication-defective M-MuLV-based vectors in mice (Okimoto and Fan, 1999) . This has allowed us to identify the first cells that are infected in vivo by M-MuLV, since these vectors cannot spread infection to other cells. We are interested in carrying out equivalent experiments with SIV-based vectors in monkeys, since this could allow identification of the cellular pathway of infection after different routes of viral exposure. As indicated above, the major challenges were likely to involve developing systems where high titers of helper-free vector could be obtained. Other investigators have described generation of some SIV-based vectors (Gundlach et al., 1997; Kirchhoff et al., 1997) . In this report, we describe generation of helper-free, replication-defective vectors based on SIVmac. A systematic comparison of different vector constructs as well as helper plasmids led to production of the desired vectors at high titers, and factors influencing the titers were elucidated.
RESULTS
The goal of these experiments was to generate helperfree SIV-based retroviral vectors. In particular, we wished to generate high-titer stocks of vectors expressing readily identifiable reporter genes for use in in vivo infections. Two reporter genes were considered: bacterial ␤-galactosidase (␤-gal), and the enhanced jellyfish green fluorescence protein (EGFP). Cells expressing either of these proteins can be readily identified by colorimetric or fluorescent stains (␤-gal) or by intrinsic fluorescence (EGFP), and other retroviral vectors expressing these proteins have been generated.
Vectors expressing ␤-gal. The first vectors expressed ␤-gal as the reporter gene, downstream from an internal ribosomal entry site (IRES), as diagrammed in Fig.   1 . For NK1, the IRES-␤-gal cassette was placed within the gag-pol region; for this vector, expression of ␤-gal would be from a "late" viral mRNA. NK2 contained the IRES-␤-gal cassette within the second exon of rev, so expression of the reporter gene would be from an "early" mRNA. To generate vector stocks, plasmids containing these vector organizations (pNK1 and pNK2, respectively) were cotransfected into 293T cells with two helper plasmids that encoded SIV structural proteins (pNK3 for gag-pol proteins and pNK4 for env proteins). pNK3 and pNK4 were patterned after helper plasmids designed by Parolin et al. for generation of HIV-1-based vectors (Parolin et al., 1994) . Supernatants from the cotransfected cells were used to infect CEMX174 cells in the presence of 8 g/ml DEAEdextran. As a negative control, supernatants from 293T cells transfected with vector plasmid but no helper plasmids were also "infected" into the CEMX174 cells. Forty-eight hours postinfection, portions of the infected cells were deposited onto glass slides by cytocentrifugation, fixed with 4% paraformaldehyde, stained for ␤-gal with X-gal, and scanned by light microscopy for X-gal positive blue cells. Modest numbers of blue cells were detected in the infected CEMX174 cells (Table 1) . However, the control supernatant from 293T cells transfected with vector plasmid alone unexpectedly also showed blue cells when infected onto the CEMX174 cells. This suggested that some of the blue cells did not reflect genuine retroviral vector infection. Indeed, treatment of the infected CEMX174 cells with the reverse transcriptase inhibitor 
a Infection of 2 ϫ 10 5 CEMX174 cells with viral vectors produced by transfection of 293T cells with the ␤-gal-expressing vector plasmid pNK1, the gag-pol helper plasmid pNK3, and the env helper plasmid pNK4 (3) (4) (5) (6) . Results are also shown of mock infections with supernatant from 293T cells transfected with pNK1 alone (1 and 2) or with 500 l of 1 mg/ml ␤-gal protein (7 and 8).
b Infections were performed in the presence or absence of 8 g/ml DEAE-dextran.
c Infections were performed in the presence or absence of 25 M AZT.
d Cells were fixed with 4% glutaraldehyde, X-gal stained at 48-h postinfection and scored for blue cells.
e This corresponded to a titer of ca. 20 GFU/ml. Deletions of gag-pol (⌬gagpol) or packaging signals (⌬) are also indicated. Some plasmids contain the CMV immediate early promoter or a bovine growth hormone polyadenylation (poly(A)) sequence. (A) NK1 contains a 3.6-kb deletion in gag-pol which is replaced with an IRES-␤-gal cassette. (B) NK2 contains the same 3.6-kb deletion in gag-pol as NK1 and contains the IRES-␤-gal cassette in the second exon of rev. (C) pNK3 contains the SIV 5ЈLTR driving expression of gag, pol, vif, vpr, and vpx and contains the bovine growth hormone poly(A) signal. (D) pNK4 contains the CMV immediate early promoter driving expression of env, tat, and rev and contains the bovine growth hormone poly(A) signal.
AZT during infection did not abolish the appearance of blue cells.
In other experiments, we found that infection of CEMX174 cells in the absence of DEAE-dextran gave blue cells only when supernatants from 293T cells cotransfected with vector plasmid and the helper plasmids were used; no blue cells were evident if supernatants from 293T cells transfected with vector plasmid alone were used (Table 1) . Moreover, in the absence of DEAEdextran the appearance of blue cells was sensitive to inhibition by AZT. The numbers of blue cells obtained under these conditions were low (Table 1, line 3) but reproducible in independent experiments. These low titers probably represented the fact that the NK1 vector had an IRES near the 5Ј end of the genome (see below). These results suggested that there was genuine SIVbased vector in the cotransfected 293T cell supernatants, but that in the presence of DEAE-dextran, transfer of ␤-gal was also occurring in the absence of infection. Gallardo et al. have previously reported the phenomenon of pseudotransduction, in which retroviral vector stocks can incorporate proteins such as ␤-gal into the viral particles and transfer the proteins into the infected cells (Gallardo et al., 1997) . It seemed quite likely that the AZT-resistant blue cells in Table 1 represented some form of pseudotransduction. To further explore the source of the AZT-resistant ␤-gal signal in the infected CEMX174 cells, we measured supernatants from the transfected 293T cells for ␤-gal enzyme activity using the ONPG assay. Significant levels of ␤-gal activity were present in supernatants from 293T cells transfected with vector plasmid alone, or cotransfected with vector plus packaging plasmids (not shown). It thus seemed likely that soluble ␤-gal in the 293T cell supernatants was being taken up by the CEMX174 cells in the presence of DEAE-dextran. Indeed, when we incubated CEMX174 cells with purified ␤-gal protein in the presence or absence of DEAE-dextran, blue cells resulted when the incubations included DEAE-dextran (Table1).
While the results of Table 1 suggested that the pseudotransduction artifact could be circumvented in CEMX174 cells by omission of the DEAE-dextran during infection, when primary rhesus macaque peripheral blood-derived mononuclear cells (PBMCs) were exposed to the transfected 293T cell supernatants, bluestained cells were evident in the absence of DEAEdextran regardless of whether helper plasmids had been cotransfected. Thus, omission of DEAE-dextran did not eliminate the pseudotransduction artifact in primary macaque PBMCs.
SIV-based vectors expressing GFP. In light of the pseudotransduction artifact discovered for the ␤-gal vectors, we tested if a different reporter gene would prove less problematic. A second generation of SIVmac-based vector constructs was prepared that expressed the enhanced jellyfish GFP protein as described under Materials and Methods (Fig. 2) . As an example, ST1EGFP is equivalent to NK2 except that it expresses EGFP instead of ␤-gal. Infection of CEMX174 cells with supernatant from 293T cells transfected with pST1EGFPSVO cotransfected with the helper plasmids showed EGFP-positive cells 4 days postinfection ( Table 2 and Fig. 3 ). Fluorescent cells were only evident when supernatant from 293T cells cotransfected with the helper plasmids were used; in addition, no EGFP-positive cells were detected when infections were carried out in the presence of 100 M PMPA (another RT inhibitor). This suggested that the EGFP signal in the infected cells resulted from genuine retroviral infection and not through pseudotransduction. The time of appearance of the EGFP signal in the infected cells also supported the idea that this reflected genuine infection. When portions of the infected cells a Infection of 2 ϫ 10 5 CEMX174 cells with viral vectors produced from transfection of 293T cells with the EGFP-expressing vector pST1EGFP, the gag-pol helper plasmid pUpSVO⌬⌿ and the env helper plasmid pS-env (2-4). Results of mock infection with supernatant from transfection of pST1EGFP alone (1) or with heat-treated ST1EGFP vector supernatant (5) are shown. Two microliters of each vector supernatant was used in the infections.
c Infections were performed in the presence or absence of 100 M PMPA.
d Cells were scanned for green fluorescence 96-h postinfection. e This number corresponds to a calculated titer of 1.17 ϫ 10 5 GFU/ml. contain two IRES-EGFP cassettes. (G) V1EGFP contains EGFP in place of nef and is replication-defective due to a deletion in env and two consecutive stop codons at the beginning of gag. In this diagram, deletions in env and nef are indicated by shaded regions, and the inserted EGFP is shown as an open box. (H) V1IRES-EGFP is identical to V1EGFP except for an IRES-EGFP cassette in the nef coding region. Plasmids encoding these vectors are designated with the prefix "p" (e.g., pV1EGFP); in some cases, an SV40 ORI has been placed on the vector (or helper) plasmid outside of the vector sequences to facilitate amplification in 293T cells and is designated by an inclusion of "SVO" in the plasmid name (e.g., pV1EGFPSVO).
were examined for green fluorescence at different times postinfection, EGFP signal was not evident at 24 and 48 h postinfection. At 72 h, cells with low-level EGFP expression were detected, while at 96 h bright green cells with high-level EGFP were found. This time course also suggests that the GFP detected in the infected cells resulted from de novo synthesis and not from pseudotransduction of EGFP.
As another test, we treated vector-containing supernatants with conditions that would inactivate retroviral particles, but that would not disrupt contaminating plasmid DNA. Vector supernatants were heat treated at 65°C for 1 h and then subjected to two cycles of freeze thawing. Infection of such treated supernatants onto CEMX174 cells yielded no fluorescent cells (Table 2) . Taken together, these results indicate that GFP is a suitable reporter gene for SIV-based vectors prepared by the cotransfection method.
Vector parameters affecting efficiency of expression. We prepared different SIVmac-based vectors expressing EGFP and compared their efficiencies in producing hightiter vector stocks. The organizations of these vectors are shown in Fig. 2 also. In each case, vector stocks were generated by cotransfecting 293T cells with a plasmid version of the vector along with a gag-pol expression plasmid and an envelope expression plasmid. For these experiments, the gag-pol expression plasmid was pUpSVO⌬⌿ and the env expression plasmid was pS-env (see below). Each vector stock was titered by infection on CMMT-CD4 cells in the presence of 1.8 g/ml DEAEdextran (Table 3) . Two sets of the vectors were prepared; within each set, all vectors were prepared at the same time. Each set of vectors was also titered twice; for each titration, all vectors in the set were assayed at the same time. In Table 3 , data from all of the titrations are presented. Since there was generally good agreement as to the relative titers of the different vectors in the different sets and assays, in subsequent tables, single representative titration sets are shown.
The ST1EGFP stock had titers of 4.3 to 5.8 ϫ 10 5 unit/ml. This vector is 8 kb in length, with a 3.6-kb deletion in gag, with a 1.4-kb IRES-EGFP cassette inserted into the second rev exon. To test if a vector with a smaller genome would give higher titers, ST1.2EGFP (6.8 kb) was prepared, which contained an additional deletion of 1.2 kb in env; however, this vector gave lower titers than ST1EGFP (four-to sevenfold lower). Vector ST3EGFP was similar to ST1.2EGFP, except that gag-pol was rendered defective by insertion of two consecutive stop codons at positions 1074 and 1077 instead of by deletion (genome length 10.4 kb). Despite the longer genome length, ST3EGFP had a higher titer (2.5-to fivefold higher than ST1.2EGFP). The lowest vector titers were obtained from vectors containing an IRES sequence near the 5Ј end of the genome. These included the vectors ST4EGFP, STX2EGFP, and ST3X2EGFP.
The vector that gave the highest titer stocks was V1EGFP. V1EGFP contains a 1.2-kb deletion in env, a 234-bp deletion in vif, two consecutive stop codons (codons 8 and 9) in gag, and substitution of the EGFP gene for a deletion in nef (genome length 9.4 kb). V1IRES-EGFP is identical to V1EGFP, except for the presence of an IRES at the beginning of the EGFP gene. V1IRES-EGFP gave stocks of somewhat lower titer than V1EGFP (1.7-to 1.9-fold lower).
Parameters affecting the helper plasmids. We also investigated the effects of different sequences and organizations in the helper plasmids on the efficiencies of vector production. Four different gag-pol expression plasmids were examined: pUpSVO, pUpSVO⌬⌿, pNK3, and pSIVSVO⌬⌿. The organizations of these helper plasmids are shown in Fig. 4 . pUpSVO is derived from a molecular clone of SIVmac239 and contains a 1.2-kb deletion in env, a 511-bp deletion in nef, and a heterologous M-MuLV LTR at the 3Ј end. pUpSVO⌬⌿ was derived from pUpSVO by deletion of the putative packaging sequence, ⌿ (Rizvi and Panganiban, 1993) . pNK3 is described above (see Fig. 1 ), and pSIVSVO⌬⌿ is a plasmid version of a complete SIVmac239 provirus from which the ⌿ sequences have been deleted. All gag-pol helper plasmids contained the SV40 origin of replication (SVO) for amplification and high expression in 293T cells. As an initial test, these helper plasmids were transfected into 293T cells by themselves, and the cells were examined for expression of gag and pol proteins by Western blot analysis using a polyclonal antibody raised against the SIVmac239 (Fig. 5 ). The results indicated efficient expression from pUpSVO and pUpSVO⌬⌿ (as measured by p27 CA protein), while there was significantly less efficient expression from pNK3. pSIVSVO⌬⌿ had levels of viral protein expression equivalent to pSIVSVO (a fulllength proviral clone of SIVmac239). These four helper plasmids were each cotransfected into 293T cells with the env expression plasmid pS-env and the vector plasmid pV1EGFPSVO. As shown in Table 4 , the pUpSVO helper plasmid gave V1EGFP titers of 1.37 ϫ 10 5 unit/ml, while deletion of the ⌿ sequences from the plasmid yielded a stock with higher titer (4.93 ϫ 10 5 unit/ml, approximately threefold higher). The pNK3 helper plasmid was relatively ineffective, giving a vector stock with a titer of 5.3 ϫ 10 3 unit/ml (on several repeat transfection and infections). Surprisingly, pSIVSVO⌬⌿, which was minimally changed from an infectious SIVmac239 provirus, produced no detectable infectious vector particles. In another experiment, a low titer of vector (ca. 10 GFU/ ml) was obtained with pSIVSVO⌬⌿ as the helper.
We next investigated the env helper plasmids. As shown in Fig. 6 , we have used two env helper plasmids, pNK4 and pS-env. These two helper plasmids are similar in that the env sequences for both are derived from 3.24 ϫ 10 5 (Ϯ0.18) 3.37 ϫ 10 5 (Ϯ0.46) ST4EGFP
1.50 ϫ 10 3 (Ϯ0.17) 1.34 ϫ 10 3 (Ϯ0.34) STX2EGFP
1.00 ϫ 10 3 (Ϯ0) 8.34 ϫ 10 2 (Ϯ1.7) ST3X2EGFP
1.72 ϫ 10 4 (Ϯ0.32) 1.23 ϫ 10 4 (Ϯ0.37) V1EGFP 5.44 ϫ 10 5 (Ϯ0.31) 6.58 ϫ 10 5 (Ϯ1.7) V1IRES-EGFP 2.82 ϫ 10 5 (Ϯ0.14) 3.87 ϫ 10 5 (Ϯ1.5) a Infection of CMMT-CD4ϩ cells with viral vectors produced by transfection of 293T cells with different vector plasmids, the gag-pol helper plasmid pUpSVO⌬⌿, and the env helper plasmid pS-env under standard conditions. Used were 2 ϫ 10 6 CMMT-CD4 ϩ for infection with 3 l of each vector supernatant. Prior experiments had determined that these amounts of vector and CMMT-CD4ϩ cells were in the linear range for titration. EGFP positive cells were scored by fluorescent microscopy 96 h after initiation of infection.
b Calculated titers are in green forming units per milliliter (GFU/ml). c Two sets of vector stocks were prepared; for each set, all vectors were prepared at the same time. Aliquots of the stocks were frozen at Ϫ80°C. Each set was then titered twice at two separate times, and the average vector titers and the ranges are shown.
SIVmac239, and expression is driven by the CMV immediate early promoter. However, the polyadenylation sequences for pNK4 are derived from the bovine growth hormone gene. Western blot analysis using polyclonal antibodies against the SIVmac239 envelope indicated that there was poor expression of the envelope proteins from pNK4, whereas the pS-env construct was efficient at expressing the viral envelope proteins (Fig. 5 ). When these two env expression plasmids were tested in parallel cotransfections with pV1EGFPSVO and pUpSVO⌬⌿, pS-env was approximately 10-fold more effective as a helper than pNK4 (Table 5 ). Two other versions of pS-env were generated, in which the viral sequences were derived from SIVmac316 (M-tropic) or SIVmac1A11 (dualtropic)-p316env and p1A11 env. p316env consistently gave titers equivalent to pS-env, while p1A11 gave somewhat lower titers (Table 5 ).
Finally, we tested the effect of the SV40 origin of replication on the vector and helper plasmids. While other investigators have demonstrated that inclusion of the SVO on plasmids leads to highly efficient expression in cells that contain SV40 large T antigen (such as 293T cells), we explicitly tested the importance of the SVO in FIG. 5. Viral protein synthesis by helper plasmids. 293T cells were transfected individually with different gag-pol helper plasmids (pUpSVO⌬⌿, pUpSVO, pNK3, and pSIVSVO⌬⌿) or env helper plasmids (pSIVSVO⌬⌿, pS-env, and pNK4). For a control, cells were transfected with pSIVSVO, a plasmid with a complete SIV provirus that produces infectious SIVmac239. Cell extracts were prepared and then subjected to SDS-PAGE and Western blotting with serum from an SIV-infected rhesus macaque that reacts with both env and gag proteins. Two different gels of the same extracts were run to allow optimal visualization of the envelope gp120/160 proteins (indicative of env gene expression) and the gag CA (p27) protein (indicative of gag [and presumably gag-pol] expression). As shown in the pSIVSVO lane, the antiserum reacted with gp160 (SU-TM) and gp120 (SU) and also with p27 (CA). The gag-pol helper plasmids pUpSVO, pUpSVO⌬⌿, and pSIVSVO⌬⌿ showed the presence of cleaved p27 protein; pUpSVO also showed higher molecular weight proteins in the gag region, suggestive of precursor polyproteins. The env helper plasmid pS-env showed synthesis of gp120/160; however, pNK4 showed substantially lower amounts of env protein (visible at longer exposures). The locations of gp160, gp120, and p27 are indicated. pNK3 5.33 ϫ 10 3 pUpSVO 1.37 ϫ 10 5 pUpSVO⌬⌿ 4.93 ϫ 10 5 pSIVSVO⌬⌿ 0 a Titers on CMMT-CD4ϩ cells of V1EGFP produced by transfection of 293T cells with the pV1EGFPSVO vector plasmid, pS-env, and the different gag-pol helper plasmids under standard conditions. Infections were carried out as described in Table 3 .
b Titers are in green forming units per milliliter (GFU/ml). a Titers on CMMT-CD4ϩ cells of V1EGFP produced by transfection of 293T cells with pV1EGFPSVO, pUpSVO⌬⌿ gag-pol helper plasmid, and different envelope helper plasmids. Infection conditions were as in Table 3 . b pNK3 and pS-env contain envelope sequences from T-lymphotropic SIVmac239. p1A11env contains envelope sequences from the dualtropic SIVmac1A11. p316env contains the macrophage tropic SIV-mac316 envelope sequences.
c Titers are in green forming units per milliliter (GFU/ml).
our SIV-based vector system. We generated pairs of vector plasmids lacking or containing SVO (e.g., pV1EGFP vs. pV1EGFPSVO) and also similar pairs of the gag-pol helper plasmids. Different combinations of these plasmids were then cotransfected into 293T cells, and the titers of the resulting vectors were measured by infection on CMMT-CD4 cells as shown in Table 6 . We consistently found 2-to 3-fold higher titers with incubation of transfected cells at 32 vs. 37°C (data not shown). This was expected, since the large T antigen in 293T cells is temperature sensitive (optimally functional at 32°C). The results indicated that the presence of the SVO on the vector plasmid resulted in 10-fold higher titers of vector. The presence or absence of the SVO on the pUp helper plasmid had little effect on vector titer, but on the pUp⌬⌿ plasmid, addition of the SVO led to approximately 2-fold higher levels of vector infectivity. Thus for the most efficient vector-helper plasmid combination, the presence of the SVO had a substantial effect on vector titer (ca. 10-fold). Chloroquine treatment of transfected 293T cells. Other investigators have shown that addition of chloroquine during plasmid transfections can increase the efficiency of expression. Therefore we tested if addition of chloroquine to the transfected 293T cells could result in higher titers of vector. Cells were treated with 50 M chloroquine 30 min before cotransfections with vector and helper plasmids and the transfections were also carried out in the presence of medium containing chloroquine. Twelve hours posttransfection the cells were switched to medium lacking chloroquine, and vector supernatants were collected 84 h thereafter. Infectivity assays indicated that chloroquine treatment increased the resulting vector titers by two-to threefold (not shown). Using the optimal vector-helper plasmid combination and chloroquine treatment of cells, V1EGFP vector stocks with titers up to 5 ϫ 10 6 GFU/ml were obtained.
Elimination of replication-competent recombinants. A major concern in design of retroviral vectors is the appearance of replication-competent recombinants (RCRs). In the case of the SIV-based vectors described here, this was a particular issue for vectors generated with the gag-pol helper plasmid pUpSVO and the env helper plasmid pS-env, since a single recombination between these two plasmids could result in a complete SIVmac239 provirus. A V1EGFP stock generated by cotransfection with these two helper plasmids was tested for the presence of RCRs by end-point dilution onto susceptible CEMX174 cells followed by serial passage of the dilutions and assays of supernatants for reverse transcriptase activity. The results indicated the presence of replication-competent SIV at a concentration of 10 2 to 10 3 IU/ml. The same vector stock had a vector concentration of 1.4 ϫ 10 5 unit/ml. Thus RCRs were present at the 10 Ϫ2 to 10 Ϫ3 level. We next tested if elimination of the ⌿ sequences from the pUpSVO plasmid would reduce this problem. In theory elimination of these sequences would have two effects: first, a single recombination event could not yield a replication-defective provirus; second, the pUpSVO transcript would not be packaged into retroviral particles. When we generated V1EGFP stocks using the pUpSVO⌬⌿ and pS-env helper plasmids, we were unable to detect RCRs in the resulting vector stock (Ͻ5 IU/ml). Thus elimination of the ⌿ site was effective in substantially reducing or eliminating RCRs from the vector stocks.
As a more sensitive test for RCRs, serial dilutions of a V1EGFP vector stock using the pUpSVO⌬ and pSenv helper plasmids were infected into CEMX174 cells, and the infected cells were serially passaged. At the fifth passage, DNA was extracted from the cells and assayed by PCR for the presence of SIV envelope sequences that were deleted in V1EGFP. The presence of these sequences would be indicative of RCRs. None of the serial dilutions resulted in RCR-positive cultures as measured by this assay. The results were consistent with the lack of RCRs as assayed by RT assays.
Efficiency of reporter expression. As described above, we generated several SIV-based vectors that express EGFP from different locations within the SIV genome, in some cases under control of an IRES. To compare the relative efficiencies of EGFP expression from the different vectors, CEMX174 cells were infected with each of the vectors and monitored for intensity of EGFP expression by flow cytometry 3 days postinfection. The results are shown in Fig. 7 . The highest intensity of fluorescence resulted from the ST1EGFP vector that expresses EGFP under control of an IRES from an early mRNA. Adding a deletion in env (ST1.2EGFP) somewhat reduced intensity of EGFP expression. Placement of the IRES-EGFP cassette into the nef region (V1IRES-EGFP) also gave somewhat lower fluorescence than ST1EGFP. In fact, the IRES did not affect the intensity of fluorescence when placed a Titers on CMMT-CD4ϩ cells of vector stocks produced by transfection of 293T cells with different vector plasmids with or without an SVO, pUpSVO⌬⌿ gag-pol helper plasmid, and the pS-env env plasmid (1-4). V1EGFP vector titers produced by 293T transfection with different gag-pol helper constructs, the pV1EGFPSVO vector plasmid, and the pS-env env plasmid (5-7). Infection conditions were as in Table 3 .
b Titers are in green forming units per milliliter (GFU/ml).
in the nef coding region, since the intensities for V1EGFP and V1IRES-EGFP were equivalent. Somewhat surprisingly, vectors containing two IRES-EGFP cassettes did not show higher efficiencies of EGFP expression than those with one IRES-EGFP cassette; indeed in general they expressed EGFP less efficiently.
DISCUSSION
In this report, we have investigated several parameters involved in SIVmac-based vector production. The first issue was the choice of reporter proteins. We found that the ␤-galactosidase protein, while having the advantage of a sensitive enzymatic assay for detection, had the important disadvantage of transfer of free ␤-gal protein during vector infections. While this problem could be circumvented in some in vitro infections by omitting DEAE-dextran, peripheral blood mononuclear cells could take up soluble ␤-gal in the absence of DEAEdextran (most likely by phagocytosis) and the X-gal staining pattern of these cells was indistinguishable from genuine NK1-infected cells (S. Kim and H. Fan, not shown) . We attempted to reduce the level of contaminating ␤-gal protein from vector supernatant by ultracentrifugation, spin dialysis, immunoadsorption, and construction of a tetracycline-inducible vector system. Attempts to physically separate ␤-gal proteins from vector particles were largely unsuccessful, perhaps due to two factors: the large size of the ␤-gal protein (480 kDa as a tetramer) and the substantial reductions in titer during concentration. Attempts to construct a replication-defective SIVbased vector that expressed ␤-gal under an inducible promoter (tet-off system; Paulus et al., 1996 Paulus et al., , 1997 Yu et al., 1996) were partially successful. We were able to produce vector stocks that contained minimal levels of ␤-gal protein, but the titers were 3 to 4 logs lower than titers from comparable vectors lacking the tet-off promoter (e.g., ST1EGFP; Kim and Fan, unpublished results) .
Unlike the ␤-gal, vectors expressing EGFP did not have the same problem with uptake of reporter protein.
While soluble EGFP was presumably present in the vector stocks, we did not find any EGFP signal in infected cells that was resistant to inhibition by the reverse transcriptase inhibitor PMPA. The most likely reason is that threshold levels of intracellular EGFP are required for detectable fluorescence (30 nM for HeLa cells, Clontech, Palo Alto, CA). The EGFP detected in the target cells resulted from de novo expression since the EGFP was sensitive to inhibition by PMPA, sensitive to inhibition by heat inactivation of the virus (therefore not resulting from carryover of vector plasmid DNA), and exhibited a timedependent increase in expression.
Next we explored parameters affecting efficient vector expression. We found that the ST1EGFP vector whose genomic length more closely resembled wild-type SIV had four-to sevenfold higher titers than ST1.2EGFP (6.8 kb). Interestingly, the largest vector, ST3EGFP (10.4 kb), produced vectors at levels comparable to ST1EGFP. The vectors also allowed us to compare different methods of rendering the vector plasmid replication-defective: deletion of gag-pol sequences versus introduction of stop codons in gag. We found 2.5-to fivefold higher titers with ST3EGFP than ST1.2EGFP (Table 2 ), suggesting that the 5Ј gag sequences may contribute to optimal vector titers. The possible role of gag-pol sequences in HIV production has been described by Parolin et al. (1994) . For HIV, inclusion of 653 nucleotides containing the 5Ј portion of the gag gene improved vector production.
The use of an IRES for heterologous gene expression in retroviral vector systems has the advantage that an IRES-gene cassette can be placed anywhere in an exon and be efficiently expressed (Kim et al., 1998) . We found that for SIV-based vectors, the position of the IRES cassette greatly affected the titer. In particular, placement of the IRES-EGFP cassette near the 5Ј end of the vector genome resulted in a substantial decrease in titer compared to when the IRES-EGFP was further away from the 5Ј end (e.g., ST4EGFP vs. ST1.2EGFP, Fig. 3 and Table 3 ). One possible reason could be that the tertiary structure of the IRES may hinder the RNA interactions necessary for packaging or dimer formation (Clever and Parslow, 1997; Laughrea et al., 1997; McCann and Lever, 1997) . Introduction of a second IRES-EGFP cassette in the gag region resulted in drastic decreases in titers (STX2EGFP and ST3X2EGFP, Table 3 ). Placing an IRES toward the 3Ј end of the vector genome (V1EGFP vs. V1IRES-EGFP, Fig.  3 ) resulted in relatively little effect on vector titer. Use of an IRES-EGFP cassette showed minimal benefits on the levels of EGFP expression; vectors with multiple IRES-EGFP cassettes actually showed less expression.
With regard to the helper gag-pol helper plasmids, deletion of the psi (⌿) packaging sequences also affected vector titers. We initially introduced the ⌿ deletion into these plasmids to decrease the formation of replication-competent recombinants, but also found a ca. threefold increase in titer (Figs. 4A and 4B, Table 4 ). One possible explanation was that with the introduction of the ⌿ deletion, there was decreased packaging of gag-pol helper plasmid RNA and a concomitant increase in packaging of vector RNA. Of two other gag-pol expression plasmids, the low vector titers obtained with pNK3 might reflect inefficient use of the bovine growth hormone poly(A) signal, or the lack of 3Ј SIV sequences ( Fig. 4 and Table 4 ). The other gag-pol helper plasmid, SIVSVO⌬⌿, was expected to provide optimal titers because it had minimal changes relative to SIVmac genomic sequences, and it was effective in the expression of the gag and envelope proteins (Fig. 5 ). However, SIVSVO⌬⌿ was the least efficient gag-pol helper plasmid (Table 4) . One potential explanation could be that processing of the gag polyprotein seemed delayed (Fig. 5) , which might indicate inefficient particle formation or proteolytic cleavage.
For the envelope helper plasmids, the heterologous bovine hormone poly(A) sequences may have been less efficient than those of the SIV LTR (Table 5) .
The presence of the SVO on the vector plasmids increased vector titers ca. 10-fold (e.g., pV1EGFP vs. pV1EGFPSVO), as expected (Table 6 ). On the other hand, the presence of the SVO on the gag-pol helper plasmid had less effect (e.g., pUp⌬⌿ vs. pUpSVO⌬⌿), which might suggest that the limiting factor in viral particle formation is vector genomic RNA.
Cotransfection of 293T cells in the presence of chloroquine increased vector titers two-to threefold. To exploit chloroquine's beneficial effect on lysosomal degradation without adversely affecting vector infectivity, we exposed the transfection reactions to chloroquine, allowing for optimal amplification of the vector, gag-pol helper, and env plasmids and then switched the cultures to media lacking chloroquine. The resulting vectors were able to infect the same range of cells as those produced in the absence of chloroquine, including rhesus macaque PBMCs, rhesus macrophages, CEMX174 cells, SupT1 cells, CMMT-CD4 cells, and Molt4-Clone8 cells (Kim and Fan, unpublished results) .
We decreased the level of RCRs in these vectors to undetectable levels (Ͻ5 IU/ml) by deleting ⌿ from the gag-pol helper plasmid. The presence of the ⌿ deletion in pUpSVO would require three recombination events to generate an RCR. First, the gag-pol helper plasmid would have to recombine twice over a small distance (132 bp) with the pV1EGFPSVO vector plasmid to recover functional ⌿ sequences, followed by recombination with the env helper plasmid to recover the native 3Ј sequences. For some applications, the likelihood of RCR formation could be reduced further by substitution of a heterologous viral envelope as described by others (Akkina et al., 1996; Chang et al., 1999; Douglas et al., 1999; Gallardo et al., 1997; Kafri et al., 1999; Li et al., 1998; Mochizuki et al., 1998) .
In summary, systematic variation of SIVmac-based vector design allowed us to optimize efficiency of vector expression plasmids and helper plasmids and to reduce the level of RCRs. While in many cases the differences by varying one parameter were relatively small (two-to fivefold), combining the optimal plasmids ultimately resulted in production of replication-defective, helper-free vector stocks of quite high titer (Ͼ10 6 /ml). Production of SIV-based helper-free stocks of these titers, without use of a heterologous viral envelope, has not been previously reported.
MATERIALS AND METHODS
Construction of vector plasmids pNK1. A 3.6-kb deletion was made in pBRmac239SpSp5Ј (a plasmid containing the 5Ј half of the proviral clone pSIV-mac239, provided by Dr. Ronald Desrosiers) by digestion with BamHI (position 1849) and BglII (position 5441) and replaced with a 3.7-kb BamHI-BamHI DNA fragment containing the Escherichia coli ␤-galactosidase gene immediately downstream of the encephalomyocarditis (EMC) virus internal ribosome entry site (Jang et al., 1989) . The 3Ј half of pSIVmac239 was introduced as a SphI (6450) to EcoRI (10279) fragment (from pBRmac239SpEЈ, provided by Dr. Ronald Desrosiers) to generate pNK1. pNK2. A 3.6-kb deletion was made in pBRmac239SpSp5Ј by digestion with BamHI (position 1849) and BglII (position 5441) and religated to generate pBRmac239SpSp5Ј⌬gagpol. The 3Ј half of pSIVmac239 was introduced as a SphI (6450) to EcoRI (10279) fragment (from pBRmac239SpEЈ) to generate pSIVmac239⌬gag-pol. Next, a 3.6-kb BamHI-BamHI IRES-␤-gal cassette was inserted into the BglII site (9118) of pSIVmac239⌬gag-pol to generate pNK2. The orientation of the IRES-␤-gal insert was determined by restriction enzyme digests.
pST1EGFP and pST1EGFPSVO. First, a 440-bp DNA fragment containing the minimal simian virus 40 (SV40) origin of replication (ORI) was inserted into the EcoRI site (10279) of pSIVmac239⌬gag-pol to generate pSIVSVO⌬gag-pol. Next, a 1.4-kb BamHI-BamHI DNA fragment containing the Aquaria victoria jellyfish-enhanced green fluorescent protein (Clontech) downstream of the EMC IRES was inserted into the BglII site (9118) of pSIVSVO⌬gag-pol to generate pST1EGFPSVO. The SV40 ORI was removed from pST1EGFPSVO by EcoRI digestion, which released a 440-bp fragment containing the SV40 ORI to generate pST1EGFP.
pV1EGFP, pV1EGFPSVO, and pV1IRES-EGFPSVO. A deletion in env (from 6603 to 7758) was introduced to pSIV⌬NU, a proviral clone of SIVmac239 containing deletions in nef and the U3 region (Gundlach et al., 1997) , to generate pSIV⌬NU⌬env. The 813-bp fragment encoding the 700-bp EGFP gene was cloned in place of nef. Expression of SIVgag-pol was blocked by introducing two stop codons at codons 8 and 9 of gag by PCR. In addition, the vif gene was replaced by a vif gene containing a deletion (Gibbs et al., 1994) , kindly provided by Dr. Ronald Desrosiers through the AIDS Research and Reference Reagent Program, resulting in pV1EGFP. The 440-bp fragment containing the SV40 ORI was cloned into the EcoRI site (10279) of pV1EGFP to produce pV1EGFPSVO. For pV1IRES-EGFPSVO, the EGFP gene of pV1EGFPSVO was replaced with a 1.4-kb DNA fragment containing an IRES-EGFP cassette.
pSTX2EGFPSVO. An amount of 3.6 kb of gag-pol sequences was removed from pSIVmac239SpSp5Ј by digestion with BamHI (1849) and BglII (5441) and replaced with a 1.4-kb IRES-EGFP BamHI-BamHI DNA cassette. Subsequently, this plasmid was digested with AvaI (1502 and 5750) to release a 2.1-kb fragment containing the IRES-EGFP insert. This 2.1-kb fragment was introduced into pST1EGFPSVO, replacing the corresponding AvaI-AvaI sequences, to produce pSTX2EGFPSVO. This vector is designed to have two IRES-EGFP inserts.
pST3EGFPSVO. 3Ј end sequences of pV1EGFPSVO from ClaI (8073) to AatII (4284 of pBR322) were replaced with the corresponding ClaI-AatII sequences from pST1EGFPSVO to produce pST3EGFPSVO.
pST3X2EGFPSVO. Sequences from BamHI (1849) to BglII (5441) were removed from pST3EGFPSVO by restriction enzyme digestion and replaced with a 1.4-kb BamHI-BamHI DNA fragment containing an IRES-EGFP cassette to generate pST3X2EGFPSVO.
pST1.2EGFPSVO. The 3Ј end of pST1EGFPSVO from SphI (6450) to AatII (4284 of pBR322) were replaced with the corresponding 3Ј sequences of pST3EGFPSVO.
pST4EGFPSVO. pSTX2EGFPSVO was first digested with ClaI (position 8073) and Aat II (position 12000). The resulting 8-kb fragment encompassing the 5Ј LTR and an IRES-EGFP cassette in place of gag and pol was ligated to a 2.6-kb fragment derived from the construct pSIVSVO. The 2.6-kb fragment was released as a ClaI (position 8073) and Aat II (position 10679) fragment and contains the 3Ј LTR and the SV40 ori.
Construction of gag-pol expression plasmids
pNK3. First, the rev response element (RRE) was introduced into pCDNA 3 (Invitrogen, Carlsbad, CA) as a ClaI (converted to a blunt end) to EcoRI fragment derived from pBRmac239(E)⌬3ЈLTR (a plasmid containing only the 5Ј half of SIVmac239, provided by Dr. Ronald Desrosiers). The fragment was inserted into the BamHI (converted to blunt end) and EcoRI site on the polylinker of pCDNA 3 . Then, the sequences from NdeI (290) to SphI (6450) that encode gag-pol but lack ⌿ (from p5ЈSIVmac239⌬⌿, see construction of pSIVSVO⌬⌿ below) were placed immediately downstream of pCDNA3's cytomegalovirus (CMV) promoter as a HindIII-HindIII fragment (after conversion of the ends to HindIII sites) into the HindIII site of pCDNA3's polylinker.
pSIVSVO⌬⌿. The putative packaging signal ⌿ (Rizvi and Panganiban, 1993) was deleted from pBRmac239SpSp5Ј by digestion with NarI (824) and KpnI (941), blunt-end filling by Klenow polymerase, and then ligating by T4-ligase to produce p5ЈSIVmac239⌬⌿. The 3Ј SIVmac239 sequences were introduced as a BamHI (1849) to AatII (4284 of pBR322) fragment to produce pSIV⌬⌿. The SV40 ORI was added at the EcoRI site (10279) as a 440-bp EcoRI-EcoRI fragment, producing pSIVSVO⌬⌿. pUpSVO⌬⌿ and pUp⌬⌿. Using a PCR approach, a deletion in env from 6347 to 7502 was introduced into pSIV⌬NU. The 3ЈLTR of this plasmid, designated pSIV⌬env⌬NU, was then replaced by a PCR-generated fragment containing the MLV-LTR with its polyadenylation signal, using the XbaI and EcoRI sites resulting in pBRmac239⌬env2pAd (Sgp, Schnell et al., 2000) . The SV40 origin of replication was introduced at the EcoRI site (10279) of Sgp to generate pUpSVO. To construct pUpSVO⌬⌿, a 117-bp deletion (NarI to KpnI) in the putative packaging sequence was made by restriction enzyme digestion. The SV40 ORI was removed from pUpSVO⌬⌿ by digestion with EcoRI to produce pUp⌬⌿.
Construction of envelope expression plasmids
pS-env. A fragment comprising nucleotides 6450 (SphI) to 10280 of the SIVmac239 proviral clone and cellular flanking regions was cloned into the HindII-EcoRI site of pCDNA-I-Amp (Invitrogen) resulting in pS-env. pNK 4 . First, the KpnI site (5775) of SIVmac239 was converted to a BamHI site by restriction digest with Asp718 followed by ligation of a BamHI linker. Sequences from the newly introduced BamHI (5775) to EcoRI (9751) of SIVmac239 that include those encoding env, tat, and rev were introduced into the BamHI and EcoRI site of pCDNA 3 that carries the bovine growth hormone poly(A) signal (Invitrogen).
Cell lines
293T cells, a human embryonic kidney cell line that expresses the simian virus 40 large T antigen (Li and Kelly, 1984) , were obtained from the American Type Tissue Culture Collection (Rockville, MD). The cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 100 g/ml streptomycin, and 300 g/ml L-glutamine. CMMT-CD4 cells (a rhesus macaque mammary tumor cell line that expresses human CD4 (Chackerian et al., 1995) ) were maintained in DMEM supplemented with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 300 g/ml glutamine, and 0.2 mg/ml geneticin (G418, at an active concentration of 700 g/ mg). sMAGI cells were maintained in DMEM with 10% FBS, 100 U/ml penicillin, 100 g/ml streptomycin, 300 g/ml glutamine, 0.2 mg/ml geneticin, and 50 U/ml hygromycin (Calbiochem, La Jolla, CA). CEMX174 (a human T-cell/B-cell hybrid cell line; AIDS Research and Reference Reagent Program, NIH) was maintained in RPMI 1640 with 10% 2mM L-glutamine.
Vector production
Vector stocks were made by transient transfections of 293T cells. Briefly, 2 ϫ 10 5 293T cells were plated 2 days prior to transfection in 6-cm tissue culture dishes. The plates were refed 2 h prior to transfection with 5 ml of fresh DMEM with 10% FBS. Transfections were performed by the calcium phosphate method using the Calphos Maximizer transfection kit (Clontech). A total of 15 g of plasmid DNA (5 g of each plasmid: pV1EGFPSVO, pUpSVO⌬⌿, and an envelope expression plasmid) were used and transfection reactions were incubated at 37°C, 5% CO 2 . Plates were refed with half volume (2.5 ml) of media 12 h posttransfection and incubated at 32°C, 5% CO 2 . Twenty-four hours after refeeding, vector supernatants were collected, filter clarified through a 0.45-m filter, and then stored frozen at Ϫ140°C.
Titration of vector stocks
Onto 12-well plates, 5 ϫ 10 4 CMMT-CD4 cells were plated 24 h prior to infection with 2 ml of media. Infections were carried out by removing media from the wells, adding 295 l of fresh media and 15 g/ml DEAEdextran, and then adding 5 l of diluted vector stock. Two hours poststart of infection, 2 ml of fresh media was added to each well. Four days later, the CMMT-CD4 cells were microscopically scanned for EGFP expression using a fluorescent microscope with a FITC filter designed for optimal EGFP detection (Chroma Technology, Brattleboro, VT). Titers of each vector stock were calculated by taking the total number of EGFP-positive colonies, multiplying that number by 200 (to correct for volume of supernatant used), and then multiplying by the dilution factor. Titers are defined as green forming units per milliliter (GFU/ml).
Infections
Onto 12-well plates, 5 ϫ 10 4 sMAGI cells were plated 24 h prior to infection with 2 ml of media. Infections were carried out by removing media from the wells, adding 295 l of fresh media, 15 g/ml DEAE-dextran, and then adding 5 l of diluted vector stock. Two hours poststart of infection, 2 ml of fresh media was added to each well. Four days later, the cells were either microscopically scanned for EGFP expression or fixed with 1% paraformaldehyde and 2% glutaraldehyde for 5 min, washed with phosphate buffered saline 3 times, and then X-gal stained for 50 min.
For CEMX174 cells, 1 ϫ 10 6 cells were plated into 12-well plates in 200 l of fresh media. Five hundred microliters of vector supernatant was added to each well and incubated at 37°C. Five hours later, 2 ml of fresh media was added to each well. Four days later, the cells were screened for EGFP expression by fluorescent microscopy or FACS.
Western blot analysis
293T cells were transfected with 5 mg of the various packaging vectors generated (pUpSVO⌬⌿, pUpSVO, pNK3, pSIVSVO⌬⌿, pSIVSVO, or pNK4) using the calcium phosphate method described above. The cells were washed with PBS 48 h posttransfection and RIPA lysates were prepared. Whole-cell lysates (20mg/lane) were electrophoresed through an 8% sodium dodecyl sulfate (SDS) polyacryamide gel. Proteins were transferred to a Hybond ECL nitrocellulose membrane (Amersham). All incubations were performed at room temperature, and membranes were washed 3 times for 10 min between incubation steps. Membranes were blocked with 5% skim milk in PBS-0.4% Tween 20 for 1 h and then incubated with a 1:20,000 dilution of sera from an SIV-mac239-infected rhesus macaque in 5% skim milk in PBS-0.05% Tween 20 for 1 h. Dilutions of secondary antibodies and detection were performed as described by the manufacturer of the enhanced chemiluminescence system (Amersham).
Flow cytometry
For flow cytometry, cultures of infected CEMX174 cells were pelleted with low-speed centrifugation and resuspended in 1 ml PBS. After 30 min at room temperature, cell suspensions were analyzed by flow cytometry with a Becton-Dickinson FACScalibur in the analytical mode. EGFPpositive cells were detected in the green fluorescence channel. Events from 5000-10,000 cells were recorded.
Characterization of vectors
Reverse transcriptase inhibition assays were performed by preloading CMMT-CD4 cells, CEMX174 cells, and sMAGI cells with 25 M 9-(2-phophonylmethoxypropyl) adenine (PMPA; Gilead Sciences, Hayward, CA (Srinivas et al., 1993) ) 1 h prior to infection with vectors. Fifty microliters of each undiluted vector was used for infection. Ninety-six hours after initiation of infection, CMMT-CD4 and CEMX174 cells were screened by fluorescent microscopy for EGFP expression. sMAGI cells were screened by fluorescent microscopy for EGFP expression and X-gal-stained for ␤-gal expression as described above. Vector stocks were tested for replicationcompetent recombinants by long-term infection of CEMX174 cells. Briefly, 1 ϫ 10 6 CEMX174 cells in 1.5 ml of media (RPMI 1640 ϩ 11.5% FBS) were infected with 500 l of serially diluted and undiluted vector stocks in triplicate. Thrice weekly for 4 weeks, 750 l of media were removed. The media removed from the cells were clarified by low-speed centrifugation and then PEG precipitated. Virion pellets were resuspended and level of reverse transcriptase activity assayed using standard reverse transcriptase activity as previously described (Spira et al., 1987) . Cells were resuspended in the remaining 1.25 ml of media and one-half of the cell suspension (0.6 ml) was removed. Cells were refed with 1.3 ml RPMI 1640 containing 11.5% FBS.
Nomenclature. Throughout this report, we have adopted the following nomenclature to distinguish between vectors and the plasmids that encode them. In all cases, plasmids are designated with the prefix "p" (e.g., pV1EGFP), while the resulting retroviral vectors do not contain the prefix (e.g., V1EGFP). In some cases, plasmids contain an SV40 ORI outside of the vector coding sequences, to allow amplification in SV40 T antigen-containing cells such as 293T; these plasmids contain "SVO" in their names (e.g., pV1EGFPSVO). All helper plasmids contain the p prefix with or without SVO as appropriate.
